@xconomy.com 2 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com 2 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com 2 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
@techcrunch.com 4 years ago
CRISPR loses Nobel to tiny machines
@techcrunch.com 4 years ago
Reshaping human health and changing lives through gene editing